Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Marth

Showing results (71-80 of 237) with videos related to

Pageof 24
Sort By:
Future Oncology (London, England)|August 9, 2024
Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in EuropeJingchuan Zhang, Sneha S Kelkar, Vimalanand S Prabhu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesotheliumSylvia Stadlmann, Hans Feichtinger, Gregor Mikuz, et al.
Geburtshilfe Und Frauenheilkunde|September 17, 2021
Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 - a Prospective Cohort TrialSamira Abdel Azim, Irene Mutz-Dehbalaie, Verena Wieser, et al.
Cancer Letters|May 26, 2004
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
Cancer Letters|January 30, 2008
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervixBirgit Volgger, Coskun Aspisirengil, Elisabeth Genser-Krimbacher, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 1, 2019
NADPH oxidase 4 expression in the normal endometrium and in endometrial cancerChristine Degasper, Andrea Brunner, Natalie Sampson, et al.
BMC Cancer|July 27, 2007
Favorable prognostic value of SOCS2 and IGF-I in breast cancerMichael C Haffner, Barbara Petridou, Jean Phillipe Peyrat, et al.
Cancer Research|March 1, 2005
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsHeidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, et al.
Cancer Science|January 31, 2019
Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancerVerena Wieser, Irina Tsibulak, Christine Degasper, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancerKurt Heim, Andreas Widschwendter, Gudrun Pirschner, et al.
Pageof 24

Showing results (71-80 of 237) with videos related to

Sort By:
Pageof 24
Future Oncology (London, England)|August 9, 2024
Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in EuropeJingchuan Zhang, Sneha S Kelkar, Vimalanand S Prabhu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 11, 2014
Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesotheliumSylvia Stadlmann, Hans Feichtinger, Gregor Mikuz, et al.
Geburtshilfe Und Frauenheilkunde|September 17, 2021
Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 - a Prospective Cohort TrialSamira Abdel Azim, Irene Mutz-Dehbalaie, Verena Wieser, et al.
Cancer Letters|May 26, 2004
A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancerHannes M Müller, Andreas Widschwendter, Heidi Fiegl, et al.
Cancer Letters|January 30, 2008
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervixBirgit Volgger, Coskun Aspisirengil, Elisabeth Genser-Krimbacher, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 1, 2019
NADPH oxidase 4 expression in the normal endometrium and in endometrial cancerChristine Degasper, Andrea Brunner, Natalie Sampson, et al.
BMC Cancer|July 27, 2007
Favorable prognostic value of SOCS2 and IGF-I in breast cancerMichael C Haffner, Barbara Petridou, Jean Phillipe Peyrat, et al.
Cancer Research|March 1, 2005
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patientsHeidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, et al.
Cancer Science|January 31, 2019
Tumor necrosis factor receptor modulator spermatogenesis-associated protein 2 is a novel predictor of outcome in ovarian cancerVerena Wieser, Irina Tsibulak, Christine Degasper, et al.
American Journal of Obstetrics and Gynecology|April 23, 2002
Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancerKurt Heim, Andreas Widschwendter, Gudrun Pirschner, et al.
Pageof 24